Molecular tumor boards in uro-oncology—prostate cancer Molekulare Tumorboards in der Uroonkologie – Prostatakarzinom
Kunath F, Heidegger I, Heck M, Mayr R, Becker C, Rausch S (2024)
Publication Type: Journal article
Publication year: 2024
Journal
Book Volume: 63
Pages Range: 899-907
Journal Issue: 9
DOI: 10.1007/s00120-024-02399-z
Abstract
The rapid development of molecular medicine has opened up new perspectives for the diagnosis and treatment of urological tumors. Urology faces the challenge of effectively treating advanced cancer, especially in view of the genetic diversity of urological tumors. The molecular tumor board offers an innovative approach to identify targeted therapy options based on the individual genetic signatures of tumor cells or tumor microenvironment-based treatment options. In this article, the concept of the molecular tumor board in urology is presented using the example of prostate cancer. We discuss the principles, applications, and future prospects of this promising approach.
Involved external institutions
Klinikum Bayreuth
Germany (DE)
Medizinische Universität Innsbruck
Austria (AT)
Klinikum rechts der Isar
Germany (DE)
Universität Regensburg
Germany (DE)
Universitätsklinikum Tübingen
Germany (DE)
Germany (DE)
Medizinische Universität Innsbruck
Austria (AT)
Klinikum rechts der Isar
Germany (DE)
Universität Regensburg
Germany (DE)
Universitätsklinikum Tübingen
Germany (DE)
How to cite
APA:
Kunath, F., Heidegger, I., Heck, M., Mayr, R., Becker, C., & Rausch, S. (2024). Molecular tumor boards in uro-oncology—prostate cancer Molekulare Tumorboards in der Uroonkologie – Prostatakarzinom. Die Urologie, 63(9), 899-907. https://doi.org/10.1007/s00120-024-02399-z
MLA:
Kunath, Frank, et al. "Molecular tumor boards in uro-oncology—prostate cancer Molekulare Tumorboards in der Uroonkologie – Prostatakarzinom." Die Urologie 63.9 (2024): 899-907.
BibTeX: Download